These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1317089)

  • 21. Quantitative analysis of nonoxynol-9 in blood.
    Yang JT; Zhao ZW
    Contraception; 1991 Feb; 43(2):161-6. PubMed ID: 1645636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents.
    Zaneveld LJ; Waller DP; Ahmad N; Quigg J; Kaminski J; Nikurs A; De Jonge C
    J Androl; 2001; 22(3):481-90. PubMed ID: 11330649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver function tests in women using intravaginal spermicide nonoxynol-9.
    Chvapil M; Droegemueller W; Earnest DL
    Fertil Steril; 1982 Feb; 37(2):281-2. PubMed ID: 6277700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonoxynol in condoms.
    Smith N
    Int J STD AIDS; 1990 Nov; 1(6):449. PubMed ID: 1965570
    [No Abstract]   [Full Text] [Related]  

  • 25. Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations.
    Harwood B; Meyn LA; Ballagh SA; Raymond EG; Archer DF; Creinin MD
    Am J Obstet Gynecol; 2008 Jan; 198(1):32.e1-7. PubMed ID: 18166301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.
    Niruthisard S; Roddy RE; Chutivongse S
    Sex Transm Dis; 1991; 18(3):176-9. PubMed ID: 1658953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of two spermicides in five countries.
    Raymond E; Alvarado G; Ledesma L; Diaz S; Bassol S; Morales E; Fernandez V; Carlos G
    Contraception; 1999 Jul; 60(1):45-50. PubMed ID: 10549452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leads from the MMWR. Toxic-shock syndrome and the vaginal contraceptive sponge.
    JAMA; 1984 Feb; 251(8):1015-6. PubMed ID: 6319769
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of a tablet drug delivery system incorporating nonoxynol-9 coprecipitated with polyvinylpyrrolidone in preventing the onset of pregnancy in rabbits.
    Zavos PM; Correa JR; Zarmakoupis-Zavos PN
    Fertil Steril; 1998 Apr; 69(4):768-73. PubMed ID: 9548171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
    Mayersak JS; Viviano CJ
    J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial.
    Raymond EG; Chen PL; Luoto J;
    Obstet Gynecol; 2004 Mar; 103(3):430-9. PubMed ID: 14990402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Birth defects and vaginal spermicides.
    Shapiro S; Slone D; Heinonen OP; Kaufman DW; Rosenberg L; Mitchell AA; Helmrich SP
    JAMA; 1982 May; 247(17):2381-4. PubMed ID: 6279895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives.
    Witter FR; Barditch-Crovo P; Rocco L; Trapnell CB
    Int J Gynaecol Obstet; 1999 May; 65(2):165-70. PubMed ID: 10405061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
    Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion.
    D'Cruz OJ; Yiv SH; Uckun FM
    AAPS PharmSciTech; 2001 Apr; 2(2):E5. PubMed ID: 14727880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Observations in vivo on spermicidal effect of nonoxynol-9 contraceptive in forms of effervescent suppository and film].
    Hu YZ
    Zhonghua Fu Chan Ke Za Zhi; 1991 Mar; 26(2):100-2, 125. PubMed ID: 1650310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of vaginally administered nonoxynol-9 in premenopausal women.
    Barditch-Crovo P; Witter F; Hamzeh F; McPherson J; Stratton P; Alexander NJ; Trapnell CB
    Contraception; 1997 Apr; 55(4):261-3. PubMed ID: 9179459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of spermicide containing nonoxynol-9 in the prevention of HIV infection.
    Bird KD
    AIDS; 1991 Jul; 5(7):791-6. PubMed ID: 1654056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the action of nonoxynol-9 and chlorhexidine on sperm.
    Sharman D; Chantler E; Dukes M; Hutchinson FG; Elstein M
    Fertil Steril; 1986 Feb; 45(2):259-64. PubMed ID: 3005050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A clinical study of the local contraceptive C-Film Lucchini].
    Porozhanova V; Bozhinova S; Khristova V
    Akush Ginekol (Sofiia); 1999; 38(3):54-6. PubMed ID: 10734685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.